Does MELOXICAM Cause Interstitial lung disease? 113 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Interstitial lung disease have been filed in association with MELOXICAM (Meloxicam). This represents 1.3% of all adverse event reports for MELOXICAM.
113
Reports of Interstitial lung disease with MELOXICAM
1.3%
of all MELOXICAM reports
19
Deaths
34
Hospitalizations
How Dangerous Is Interstitial lung disease From MELOXICAM?
Of the 113 reports, 19 (16.8%) resulted in death, 34 (30.1%) required hospitalization, and 19 (16.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MELOXICAM. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does MELOXICAM Cause?
Drug ineffective (1,815)
Arthralgia (819)
Drug hypersensitivity (776)
Pain (709)
Pain in extremity (603)
Joint swelling (566)
Peripheral swelling (557)
Dizziness (542)
Fatigue (532)
Nausea (527)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MELOXICAM Alternatives Have Lower Interstitial lung disease Risk?
MELOXICAM vs MELPERONE
MELOXICAM vs MELPHALAN
MELOXICAM vs MEMANTINE
MELOXICAM vs MENINGOCOCCAL GROUP B VACCINE
MELOXICAM vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN